Viewing Study NCT06745193


Ignite Creation Date: 2025-12-25 @ 1:11 AM
Ignite Modification Date: 2026-01-07 @ 11:40 AM
Study NCT ID: NCT06745193
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-12-20
First Post: 2024-12-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal Cancer
Sponsor: Peking University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module